Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Zevra Therapeutics Inc
NASDAQ:ZVRA
Price:
8.85
USD
-3.38%
Market Closed
Market Cap:
$498.3m
Relative Value
The Relative Value of one ZVRA stock under the Base Case scenario is hidden USD. Compared to the current market price of 8.85 USD, Zevra Therapeutics Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZVRA Relative Value
HIDDEN
Multiples Across Competitors
ZVRA Competitors Multiples
Zevra Therapeutics Inc Competitors
Zevra Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
497.5m USD | 6 | 14.2 | -15.4 | -12.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.7 | 57 | 38.2 | 41 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.5B CHF | 4.6 | 30.1 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.5 | 16.2 | 10.1 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.5B GBP | 5.1 | 31.5 | 15 | 22 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13 | 9.1 | 10.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 19.7 | 7.4 | 9.8 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.3B EUR | 1.7 | 8.2 | 7.6 | 7.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
